Tominaga E

No ORCID on file · 10 papers in corpus · active 1999-2019

Study types

  • article 1
  • other 1
  • review 1

Condition tags

  • endometriosis 3
2019
Case Reports in Obstetrics and Gynecology ·doi:10.1155/2019/8607417

Pelvic inflammatory disease (PID) sometimes develops after intrauterine insemination (IUI). We herein present a case of PID which developed after IUI performed after abdominal modified radical trachelectomy (AmRT) and was treated with lapar…

2019
Oncology reports ·doi:10.3892/or.2019.7353

Endometrial polyps are common, yet the molecular mechanisms underlying their formation and progression remain unclear. We examined gene mutations possibly related to the pathogenesis of endometrial polyps, as well as to their clinical featu…

2017
Oncology letters ·doi:10.3892/ol.2017.6891

Epigenetic regulatory mechanisms are a current focus in studies investigating cancer. Chromatin remodeling alters chromatin structure and regulates gene expression, and aberrant chromatin remodeling is involved in carcinogenesis. AT-rich in…

2017
Oncology letters ·doi:10.3892/ol.2017.5582

Cancer typically develops due to genetic abnormalities, but a single gene abnormality cannot completely account for the onset of cancer. The Cancer Genome Atlas (CGA) project was conducted for the cross-sectional genome-wide analysis of num…

review 2016
Oncology reports ·doi:10.3892/or.2015.4421

The AT-rich interacting domain‑containing protein 1A gene (ARID1A) encodes ARID1A, a member of the SWI/SNF chromatin remodeling complex. Mutation of ARID1A induces changes in expression of multiple genes (CDKN1A, SMAD3, MLH1 and PIK3IP1) vi…

other 2015
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1097/IGC.0000000000000377

OBJECTIVE: Synchronous primary endometrial and ovarian cancers have been an important topic in clinical medicine because it is sometimes difficult to distinguish whether there are 2 primary tumors or a single primary tumor and an associated…

2015
EXCLI journal ·doi:10.17179/excli2014-590

Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are useful for early and accurate diagnosis and few treatments other than surgery. However, use of microRNAs (miRNAs) that induces gene downregu…

2014
Molecular and clinical oncology ·doi:10.3892/mco.2014.397

Lynch syndrome is a hereditary ovarian cancer with a prevalence of 0.9-2.7%. Lynch syndrome accounts for 10-15% of hereditary ovarian cancers, while hereditary breast and ovarian cancer syndrome accounts for 65-75% of these cancers. The lif…

2013
Oncology reports ·doi:10.3892/or.2013.2221

Cases of endometrial cancer have increased in recent years, but the prognosis of patients with this disease has also been improved by combined modality therapy with surgery, radiotherapy and chemotherapy. However, th…

article 1999
Gynecologic oncology ·doi:10.1006/gyno.1998.5284

ObjectiveOvarian clear cell carcinoma is commonly associated with pelvic endometriosis. We retrospectively evaluated clinicopathological data on the association between ovarian clear cell carcinoma and pelvic endometriosis.MethodsBetween 19…